Literature DB >> 15457566

Expansion of endothelial surface by an increase of vessel diameter during tumor angiogenesis in experimental and hepatocellular and pancreatic cancer.

Eduard Ryschich1, Eduard Schmidt, Sasa-Marcel Maksan, Ernst Klar, Jan Schmidt.   

Abstract

AIM: A low vessel density is a common feature of malignant tumors. We suggested that the expansion of vessel diameter might reconstitute the oxygen and nutritient's supply in this situation. The aim of the present study was to compare the number and diameter of blood vessels in pancreatic and liver carcinoma with normal tissue.
METHODS: Tumor induction of pancreatic (DSL6A) or hepatocellular (Morris-hepatoma) carcinoma was performed in male Lewis (pancreatic cancer) and ACI (hepatoma) rats by an orthotopic inoculation of solid tumor fragments (pancreatic cancer) or tumor cells (hepatoma). Six weeks (pancreatic cancer) or 12 d (hepatoma) after tumor implantation, the tumor microvasculature as well as normal pancreatic or liver blood vessels were investigated by intravital microscopy. The number of perfused blood vessels in tumor and healthy tissue was assessed by computer-assisted image analysis.
RESULTS: The vessel density in healthy pancreas (565+/-89 n/mm(2)) was significantly higher compared to pancreatic cancer (116+/-36 n/mm(2)) (P<0.001). Healthy liver showed also a significantly higher vessel density (689+/-36 n/mm(2)) compared to liver carcinoma (286+/-32 n/mm(2)) (P<0.01). The comparison of diameter frequency showed a significant increase of vessel diameter in both malignant tumors compared to normal tissue (P<0.05).
CONCLUSION: The expansion of endothelial cells during tumor angiogenesis is accompanied to a large extent by an increase of vessel diameter rather than by formation of new blood vessels. This may be a possible adaptive mechanism by which experimental pancreatic and hepatocellular cancers expand their endothelial diffusion surface of endothelium to compensate for inadequate neoangiogenesis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15457566      PMCID: PMC4611264          DOI: 10.3748/wjg.v10.i21.3171

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  21 in total

1.  Primary tumor size-dependent inhibition of angiogenesis at a secondary site: an intravital microscopic study in mice.

Authors:  A Sckell; N Safabakhsh; M Dellian; R K Jain
Journal:  Cancer Res       Date:  1998-12-15       Impact factor: 12.701

Review 2.  Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis.

Authors:  D Hanahan; J Folkman
Journal:  Cell       Date:  1996-08-09       Impact factor: 41.582

3.  Tumor vascularity: a histological measure of angiogenesis and hypoxia.

Authors:  C M West; R A Cooper; J A Loncaster; D P Wilks; M Bromley
Journal:  Cancer Res       Date:  2001-04-01       Impact factor: 12.701

Review 4.  Tumor angiogenesis: past, present and the near future.

Authors:  R S Kerbel
Journal:  Carcinogenesis       Date:  2000-03       Impact factor: 4.944

5.  Measuring VEGF-Flk-1 activity and consequences of VEGF-Flk-1 targeting in vivo using intravital microscopy: clinical applications.

Authors:  P Vajkoczy; A Thurnher; K P Hirth; L Schilling; P Schmiedek; A Ullrich; M D Menger
Journal:  Oncologist       Date:  2000

6.  Induction of angiogenesis during the transition from hyperplasia to neoplasia.

Authors:  J Folkman; K Watson; D Ingber; D Hanahan
Journal:  Nature       Date:  1989-05-04       Impact factor: 49.962

7.  Transformation of the microvascular system during multistage tumorigenesis.

Authors:  Eduard Ryschich; Jan Schmidt; Günter J Hämmerling; Ernst Klar; Ruth Ganss
Journal:  Int J Cancer       Date:  2002-02-20       Impact factor: 7.396

8.  Derivation of ductlike cell lines from a transplantable acinar cell carcinoma of the rat pancreas.

Authors:  O S Pettengill; R A Faris; R H Bell; E T Kuhlmann; D S Longnecker
Journal:  Am J Pathol       Date:  1993-07       Impact factor: 4.307

Review 9.  Angiogenesis in cancer, vascular, rheumatoid and other disease.

Authors:  J Folkman
Journal:  Nat Med       Date:  1995-01       Impact factor: 53.440

10.  Morphologic and hemodynamic comparison of tumor and healing normal tissue microvasculature.

Authors:  M W Dewhirst; C Y Tso; R Oliver; C S Gustafson; T W Secomb; J F Gross
Journal:  Int J Radiat Oncol Biol Phys       Date:  1989-07       Impact factor: 7.038

View more
  5 in total

1.  Rapamycin induces regression of endometriotic lesions by inhibiting neovascularization and cell proliferation.

Authors:  M W Laschke; A Elitzsch; C Scheuer; J H Holstein; B Vollmar; M D Menger
Journal:  Br J Pharmacol       Date:  2006-08-07       Impact factor: 8.739

2.  Fast microbubble dwell-time based ultrasonic molecular imaging approach for quantification and monitoring of angiogenesis in cancer.

Authors:  Marybeth A Pysz; Ismayil Guracar; Lu Tian; Jürgen K Willmann
Journal:  Quant Imaging Med Surg       Date:  2012-06-15

3.  A Biomimetic Microfluidic Tumor Microenvironment Platform Mimicking the EPR Effect for Rapid Screening of Drug Delivery Systems.

Authors:  Yuan Tang; Fariborz Soroush; Joel B Sheffield; Bin Wang; Balabhaskar Prabhakarpandian; Mohammad F Kiani
Journal:  Sci Rep       Date:  2017-08-24       Impact factor: 4.379

4.  Elongation, proliferation & migration differentiate endothelial cell phenotypes and determine capillary sprouting.

Authors:  Amina A Qutub; Aleksander S Popel
Journal:  BMC Syst Biol       Date:  2009-01-26

Review 5.  Contrast-enhanced endoscopic ultrasound.

Authors:  Christoph F Dietrich; M Sharma; M Hocke
Journal:  Endosc Ultrasound       Date:  2012-10       Impact factor: 5.628

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.